《內地樓市》碧桂園(02007.HK)安徽廬江西江樾項目第二次集中交付454伙
碧桂園(02007.HK)在公眾號發布消息指,10月上旬,安徽廬江西江樾項目如期交付,共有454戶業主順利拿到新家鑰匙。
據內媒《觀點新媒體》報道,這是項目今年第二次集中交付,早前在5月下旬,該項目已提前一個月實現品質交付290餘套;項目原先交付計劃時間表是分三批次,分別在5月、6月、9月交付。
碧桂園在位於廬江縣位於安徽省中部,合肥市南部,面積2,400平方公里,現有項目8個。
截至2023年9月30日,碧桂園在安徽省內共實現39個項目、60個批次,約20,664套房屋的如期交付,年內還有待交付房屋近1.7萬套。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.